Skip to main content

Find Clinical Trials

Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,003 public trials 2,033 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma

NCT00416832

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Not specified

View Trial Details

Completed

Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma

NCT00398554

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Klinikum Augsburg Augsburg, Germany

Charite University Medical Center of Berlin Berlin, Germany

Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany

Universitaets - Kinderklinik Erlangen, Germany

View Trial Details

Completed

Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome

NCT02212561

Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +17 more
Locations: Phoenix Children's Hospital Phoenix, Arizona, United States

Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States

University of Chicago Chicago, Illinois, United States

Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma

NCT00433459

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Universitaetsklinikum Giessen-Marburg Giessen, Germany

Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom

View Trial Details

Completed

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

NCT01010217

Conditions: Anemia, Anemia, Aplastic, Blood Protein Disorders, +38 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma

NCT02492750

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Phase I/IIA Study of CART19 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Leukemia and Lymphoma

NCT01626495

Conditions: B Cell Leukemia, B Cell Lymphoma, Hematologic Diseases, +13 more
Locations: CHOP - http://www.chop.edu/service/oncology/pediatric-cancer-research/cart-19-trial.html Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Investigating the Effect of Deep Sea Krill Oil Supplementation in Osteoarthritis of the Knee

NCT03483090

Conditions: Arthritis, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations: University of the Sunshine Coast Clinical Trials Centre, Morayfield Health Hub Morayfield, Queensland, Australia

University of the Sunshine Coast Clinical Trials Centre, USC Health Clinics Sippy Downs, Queensland, Australia

CSIRO Nutrition and Health Research Clinic Adelaide, South Australia, Australia

Emeritus Research Camberwell, Victoria, Australia

View Trial Details

Completed

Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

NCT00992446

Conditions: Adult Diffuse Large B-Cell Lymphoma, B-Cell Non-Hodgkin Lymphoma, Follicular Lymphoma, +17 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma

NCT00211185

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Birmingham Hematology and Oncology Birmingham, Alabama, United States

Hematology Oncology Associates Phoenix, Arizona, United States

Stanford Cancer Center Stanford, California, United States

Rocky Mountain Cancer Center Denver, Colorado, United States

View all 49 locations

View Trial Details